BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33351997)

  • 1. MRI Detection of Changes in Tissue Sodium Concentration in Brain Metastases after Stereotactic Radiosurgery: A Feasibility Study.
    A Mohamed S; Adlung A; Ruder AM; Hoesl MAU; Schad L; Groden C; Giordano FA; Neumaier-Probst E
    J Neuroimaging; 2021 Mar; 31(2):297-305. PubMed ID: 33351997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-delayed contrast-enhanced MRI improves detection of brain metastases and apparent treatment volumes.
    Kushnirsky M; Nguyen V; Katz JS; Steinklein J; Rosen L; Warshall C; Schulder M; Knisely JP
    J Neurosurg; 2016 Feb; 124(2):489-95. PubMed ID: 26361281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal evolution of perfusion parameters in brain metastases treated with stereotactic radiosurgery: comparison of intravoxel incoherent motion and dynamic contrast enhanced MRI.
    Kapadia A; Mehrabian H; Conklin J; Symons SP; Maralani PJ; Stanisz GJ; Sahgal A; Soliman H; Heyn CC
    J Neurooncol; 2017 Oct; 135(1):119-127. PubMed ID: 28669014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trial.
    Zindler JD; Bruynzeel AME; Eekers DBP; Hurkmans CW; Swinnen A; Lambin P
    BMC Cancer; 2017 Jul; 17(1):500. PubMed ID: 28743240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results.
    Fiorentino A; Giaj-Levra N; Tebano U; Mazzola R; Ricchetti F; Fersino S; Di Paola G; Aiello D; Ruggieri R; Alongi F
    Radiol Med; 2017 Sep; 122(9):676-682. PubMed ID: 28447313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion and Perfusion MRI Predicts Response Preceding and Shortly After Radiosurgery to Brain Metastases: A Pilot Study.
    Shah AD; Shridhar Konar A; Paudyal R; Oh JH; LoCastro E; Nuñez DA; Swinburne N; Vachha B; Ulaner GA; Young RJ; Holodny AI; Beal K; Shukla-Dave A; Hatzoglou V
    J Neuroimaging; 2021 Mar; 31(2):317-323. PubMed ID: 33370467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of early changes in the post-radiosurgery vestibular schwannoma microenvironment using multinuclear MRI.
    Lewis D; McHugh DJ; Li KL; Zhu X; Mcbain C; Lloyd SK; Jackson A; Pathmanaban ON; King AT; Coope DJ
    Sci Rep; 2021 Aug; 11(1):15712. PubMed ID: 34344960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and imaging characteristics of difficult to detect retrospectively identified brain metastases in patients receiving repeat courses of stereotactic radiosurgery.
    Fairchild A; Salama JK; Godfrey D; Wiggins WF; Ackerson BG; Oyekunle T; Niedzwiecki D; Fecci PE; Kirkpatrick JP; Floyd SR
    J Neurooncol; 2024 Mar; 167(1):219-227. PubMed ID: 38340295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic laser ablation as treatment for brain metastases that recur after stereotactic radiosurgery: a multiinstitutional experience.
    Ali MA; Carroll KT; Rennert RC; Hamelin T; Chang L; Lemkuil BP; Sharma M; Barnholtz-Sloan JS; Myers C; Barnett GH; Smith K; Mohammadi AM; Sloan AE; Chen CC
    Neurosurg Focus; 2016 Oct; 41(4):E11. PubMed ID: 27690654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-treatment factors associated with detecting additional brain metastases at stereotactic radiosurgery.
    Wardak Z; Augustyn A; Zhu H; Mickey BE; Whitworth LA; Madden CJ; Barnett SL; Abdulrahman RE; Nedzi LA; Timmerman RD; Choe KS
    J Neurooncol; 2016 Jun; 128(2):251-7. PubMed ID: 26966096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interval Change in Diffusion and Perfusion MRI Parameters for the Assessment of Pseudoprogression in Cerebral Metastases Treated With Stereotactic Radiation.
    Knitter JR; Erly WK; Stea BD; Lemole GM; Germano IM; Doshi AH; Nael K
    AJR Am J Roentgenol; 2018 Jul; 211(1):168-175. PubMed ID: 29708785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric feasibility of brain stereotactic radiosurgery with a 0.35 T MRI-guided linac and comparison vs a C-arm-mounted linac.
    Slagowski JM; Redler G; Malin MJ; Cammin J; Lobb EC; Lee BH; Sethi A; Roeske JC; Flores-Martinez E; Stevens T; Yenice KM; Green O; Mutic S; Aydogan B
    Med Phys; 2020 Nov; 47(11):5455-5466. PubMed ID: 32996591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of conformity index and gradient index in patients undergoing stereotactic radiosurgery for a single metastatic tumor.
    Aiyama H; Yamamoto M; Kawabe T; Watanabe S; Koiso T; Sato Y; Higuchi Y; Ishikawa E; Yamamoto T; Matsumura A; Kasuya H
    J Neurosurg; 2018 Dec; 129(Suppl1):103-110. PubMed ID: 30544326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality Assessment of Stereotactic Radiosurgery of a Melanoma Brain Metastases Model Using a Mouselike Phantom and the Small Animal Radiation Research Platform.
    Wu CC; Chaudhary KR; Na YH; Welch D; Black PJ; Sonabend AM; Canoll P; Saenger YM; Wang TJC; Wuu CS; Hei TK; Cheng SK
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):191-201. PubMed ID: 28816146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extent of surrounding edema does not correlate with acute complications after radiosurgery for melanoma brain metastases.
    Jardim A; Scott J; Drew Z; Foote MC; Sadasivan AP; Hall B; Olson SL; Shanker M; Pinkham MB
    J Neurooncol; 2019 Dec; 145(3):581-585. PubMed ID: 31691060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
    Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
    Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A matched-pair analysis comparing stereotactic radiosurgery with whole-brain radiotherapy for patients with multiple brain metastases.
    El Shafie RA; Celik A; Weber D; Schmitt D; Lang K; König L; Bernhardt D; Höne S; Forster T; von Nettelbladt B; Adeberg S; Debus J; Rieken S
    J Neurooncol; 2020 May; 147(3):607-618. PubMed ID: 32239433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.